205 related articles for article (PubMed ID: 28438925)
21. Characterization of novel Mycobacterium tuberculosis and Mycobacterium smegmatis mutants hypersusceptible to beta-lactam antibiotics.
Flores AR; Parsons LM; Pavelka MS
J Bacteriol; 2005 Mar; 187(6):1892-900. PubMed ID: 15743935
[TBL] [Abstract][Full Text] [Related]
22. Evaluation of biochemical and molecular polymorphism in extended spectrum β-lactamases of Mycobacterium tuberculosis clinical isolates.
Sharma AK; Vats P
Indian J Tuberc; 2019 Jan; 66(1):92-98. PubMed ID: 30797291
[TBL] [Abstract][Full Text] [Related]
23. Sensitivity and specificity of various beta-lactam antibiotics and phenotypical methods for detection of TEM, SHV and CTX-M extended-spectrum beta-lactamases.
Bedenic B; Vranes J; Mihaljevic Lj; Tonkic M; Sviben M; Plecko V; Kalenic S
J Chemother; 2007 Apr; 19(2):127-39. PubMed ID: 17434820
[TBL] [Abstract][Full Text] [Related]
24. Meropenem-clavulanic acid has high in vitro activity against multidrug-resistant Mycobacterium tuberculosis.
Davies Forsman L; Giske CG; Bruchfeld J; Schön T; Juréen P; Ängeby K
Antimicrob Agents Chemother; 2015; 59(6):3630-2. PubMed ID: 25824227
[TBL] [Abstract][Full Text] [Related]
25. Tuberculosis and beta-lactam antibiotics.
Gun MA; Bozdogan B; Coban AY
Future Microbiol; 2020 Jul; 15():937-944. PubMed ID: 32762449
[TBL] [Abstract][Full Text] [Related]
26. Phosphate Promotes the Recovery of Mycobacterium tuberculosis β-Lactamase from Clavulanic Acid Inhibition.
Elings W; Tassoni R; van der Schoot SA; Luu W; Kynast JP; Dai L; Blok AJ; Timmer M; Florea BI; Pannu NS; Ubbink M
Biochemistry; 2017 Nov; 56(47):6257-6267. PubMed ID: 29087696
[TBL] [Abstract][Full Text] [Related]
27. Identification of a novel multidrug efflux pump of Mycobacterium tuberculosis.
Danilchanka O; Mailaender C; Niederweis M
Antimicrob Agents Chemother; 2008 Jul; 52(7):2503-11. PubMed ID: 18458127
[TBL] [Abstract][Full Text] [Related]
28. Hydrolysis of clavulanate by Mycobacterium tuberculosis β-lactamase BlaC harboring a canonical SDN motif.
Soroka D; Li de la Sierra-Gallay I; Dubée V; Triboulet S; van Tilbeurgh H; Compain F; Ballell L; Barros D; Mainardi JL; Hugonnet JE; Arthur M
Antimicrob Agents Chemother; 2015 Sep; 59(9):5714-20. PubMed ID: 26149997
[TBL] [Abstract][Full Text] [Related]
29. Revisiting the β-Lactams for Tuberculosis Therapy with a Compound-Compound Synthetic Lethality Approach.
Xiao S; Guo H; Weiner WS; Maddox C; Mao C; Gunosewoyo H; Pelly S; White EL; Rasmussen L; Schoenen FJ; Aubé J; Bishai WR; Lun S
Antimicrob Agents Chemother; 2019 Nov; 63(11):. PubMed ID: 31427291
[TBL] [Abstract][Full Text] [Related]
30. Collateral Sensitivity to β-Lactam Drugs in Drug-Resistant Tuberculosis Is Driven by the Transcriptional Wiring of BlaI Operon Genes.
Trigos AS; Goudey BW; Bedő J; Conway TC; Faux NG; Wyres KL
mSphere; 2021 Jun; 6(3):e0024521. PubMed ID: 34047652
[TBL] [Abstract][Full Text] [Related]
31. Meropenem-clavulanic acid shows activity against Mycobacterium tuberculosis in vivo.
England K; Boshoff HI; Arora K; Weiner D; Dayao E; Schimel D; Via LE; Barry CE
Antimicrob Agents Chemother; 2012 Jun; 56(6):3384-7. PubMed ID: 22450968
[TBL] [Abstract][Full Text] [Related]
32. The Discovery of 2-Aminobenzimidazoles That Sensitize Mycobacterium smegmatis and M. tuberculosis to β-Lactam Antibiotics in a Pattern Distinct from β-Lactamase Inhibitors.
Nguyen TV; Blackledge MS; Lindsey EA; Minrovic BM; Ackart DF; Jeon AB; Obregón-Henao A; Melander RJ; Basaraba RJ; Melander C
Angew Chem Int Ed Engl; 2017 Mar; 56(14):3940-3944. PubMed ID: 28247991
[TBL] [Abstract][Full Text] [Related]
33. Susceptibilities of ESBL-producing Enterobacteriaceae to ertapenem, meropenem and piperacillin-tazobactam with and without clavulanic acid.
Raveh D; Yinnon AM; Broide E; Rudensky B
Chemotherapy; 2007; 53(3):185-9. PubMed ID: 17347564
[TBL] [Abstract][Full Text] [Related]
34. Uncovering Beta-Lactam Susceptibility Patterns in Clinical Isolates of Mycobacterium tuberculosis through Whole-Genome Sequencing.
Olivença F; Nunes A; Macedo R; Pires D; Silveiro C; Anes E; Miragaia M; Gomes JP; Catalão MJ
Microbiol Spectr; 2022 Aug; 10(4):e0067422. PubMed ID: 35695524
[TBL] [Abstract][Full Text] [Related]
35. Comparison of antimicrobial resistance of Acinetobacter baumannii clinical isolates from Shanghai and Hong Kong.
Ling TK; Ying CM; Lee CC; Liu ZK
Med Princ Pract; 2005; 14(5):338-41. PubMed ID: 16103700
[TBL] [Abstract][Full Text] [Related]
36. Can the Etest correctly determine the MICs of beta-lactam and cephalosporin antibiotics for beta-lactamase-negative ampicillin-resistant Haemophilus influenzae?
Billal DS; Hotomi M; Yamanaka N
Antimicrob Agents Chemother; 2007 Sep; 51(9):3463-4. PubMed ID: 17606681
[No Abstract] [Full Text] [Related]
37. [Beta-lactam inhibitors of beta-lactamases in Mycobacterium].
Galán JC
Rev Esp Quimioter; 1998 Dec; 11(4):386-8. PubMed ID: 10336326
[No Abstract] [Full Text] [Related]
38. CRISPRi-mediated characterization of novel anti-tuberculosis targets: Mycobacterial peptidoglycan modifications promote beta-lactam resistance and intracellular survival.
Silveiro C; Marques M; Olivença F; Pires D; Mortinho D; Nunes A; Pimentel M; Anes E; Catalão MJ
Front Cell Infect Microbiol; 2023; 13():1089911. PubMed ID: 37009497
[TBL] [Abstract][Full Text] [Related]
39. Optimizing β-Lactams against Tuberculosis.
de Jager VR; Vanker N; van der Merwe L; van Brakel E; Muliaditan M; Diacon AH
Am J Respir Crit Care Med; 2020 May; 201(9):1155-1157. PubMed ID: 31922901
[No Abstract] [Full Text] [Related]
40. Crystal structures of the transpeptidase domain of the Mycobacterium tuberculosis penicillin-binding protein PonA1 reveal potential mechanisms of antibiotic resistance.
Filippova EV; Kieser KJ; Luan CH; Wawrzak Z; Kiryukhina O; Rubin EJ; Anderson WF
FEBS J; 2016 Jun; 283(12):2206-18. PubMed ID: 27101811
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
